December 10, 2007 - Smith & Nephew Inc.’s Orthopaedic Reconstruction business recently announced the release of six-year clinical data that reportedly confirms the clinical superiority of the BIRMINGHAM HIP Resurfacing System (BHR).
The report was issued by the Australian Orthopaedic Association National Joint Replacement Registry, one of the most comprehensive registries of its kind.
Data was tracked from September 1999 to December 2006 and reportedly revealed that the BHR device has the highest hip resurfacing system survivability rate among all of its established competitors for which data had been collected, highlighting the system’s continuing exceptional clinical performance.
By carefully studying the timing and reasons for revision surgery as well as mortality rates, the registry measures the success rates of products and procedures across Australia. This year’s report is based on the analysis of 332,700 hip and knee procedures undertaken in 271,188 patients with a procedure date from September 1999 through December 2006.
For more information: www.birminghamhipresurfacing.com
April 28, 2020 
